Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older (any sex) who have been diagnosed with Stage II to Stage IIIb non-small cell lung cancer (a type of lung cancer), confirmed through a tissue sample test
- People whose treatment plan includes radiation therapy directed at the body from outside (using photon beams), with or without other treatments such as chemotherapy or immunotherapy
- People with any number of radiation treatment sessions planned, and any number or location of tumours affected
- People whose general health and ability to carry out daily activities falls within a certain range — a doctor will assess this using a standard scale (confirm with trial site)
- People who are able to have MRI scans
- People who have read, understood, and signed a consent form agreeing to take part in the study procedures
Who may not be able to join:
- People who have a medical reason that prevents them from having an MRI scan safely — for example, certain metal implants, devices, or objects inside the body (such as a pacemaker, cochlear implant, aneurysm clip, internal defibrillator, certain stents, or similar items), a medication patch, a prosthetic limb, or conditions such as claustrophobia (fear of enclosed spaces) or pregnancy
- Women who are pregnant or currently trying to become pregnant
- People who experience pain when lying flat on their back, or who are unable to raise their arm above their head while lying down
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amit Sawant, PhD, University of Maryland, Baltimore
Phone: 410-328-6080
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To investigate if time-resolved, multicycle volumetric motion modeling and monitoring gives improved spatiotemporal localization of the tumor target and OARs compared to current standard-of-care 4DCT-based motion modeling and monitoring
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.